Only 10 percent of treatments in Danish intensive care units are backed by strong scientific evidence, prompting a major research effort to improve patient safety and reduce waste across the Nordics. Denmark is taking on the leading role in a new Nordic collaboration, which wil test and validate common treatments in intensive care in Denmark and the rest of the Nordics.
Insufficient Evidence Behind Critical Treatments in Intensive Care in Denmark
In Denmark’s intensive care units, some of the sickest patients in the country receive life-saving treatment every day. However, a startling fact has emerged: only about 10 percent of these treatments are supported by what medical experts consider high-quality scientific research. According to Danish experts, the majority of interventions are based on tradition or clinical experience rather than proven efficacy.
This has raised concern among health professionals but is not intended to alarm the public. Most treatments in intensive care in Denmark are still considered beneficial, yet the lack of robust scientific validation means there could be treatments in use that are ineffective or even harmful.
A Multinational Effort to Improve Medical Practices
To address this issue, Denmark is taking a leading role in a new Nordic collaboration aimed at testing and validating common medical treatments. Under the leadership of Professor Anders Perner at Copenhagen’s Rigshospitalet, the initiative draws on data from over 30 million people across the Nordic region. The goal is to ensure that every medical procedure, drug, and intervention used in hospitals is grounded in solid evidence.
A similar effort conducted 15 years ago led to a critical discovery. A synthetic fluid known as hydroxyethyl starch (HES), widely used at the time to treat sepsis, was found to cause serious side effects. Research showed that one in 13 patients treated with HES died due to complications related to the drug. Following the research, hospitals stopped using it, saving thousands of lives in Denmark and abroad.
Streamlining Research in Intensive Care in Denmark to Get Faster Answers
One of the breakthroughs of the Nordic collaboration is its ability to launch clinical trials swiftly. By working within a pre-approved framework across multiple countries, the usual bureaucratic delays are avoided. This fast-track process allows doctors to quickly test suspicions about ineffective treatments and update clinical practices accordingly.
For instance, there is an ongoing debate in Denmark about whether a certain protein solution called albumin should be used for patients suffering circulatory failure. Half of the country’s intensive care doctors use it, while the other half do not. With the help of multi-country trials, doctors aim to resolve such discrepancies quickly and conclusively.
Exposing and Reducing Healthcare Waste
Aside from improving patient outcomes, this evidence-based approach has another major benefit: reducing financial waste. Experts estimate that 20 to 30 percent of healthcare spending in Denmark is lost on treatments and procedures that provide little to no value. Given that the national healthcare system handles an annual budget of roughly 150 billion Danish kroner, this suggests that as much as 30 to 45 billion kroner may be spent on unnecessary care.
Reducing this waste would not only free up resources for more effective treatments but also support a healthcare system under growing pressure from an aging population and a declining workforce in the healthcare sector.
Collaborative Projects Across the Nordics
The Danish-led initiative is just one piece of a broader Scandinavian effort. In Finland, a similar project is underway to improve pediatric care, while Norway is focusing on cancer treatments. Together, these programs aim to set new standards for clinical validation that can be adopted worldwide.
The ultimate objective is not to cut costs, but to maximize the value of every healthcare intervention. With better data, streamlined testing procedures, and cross-border collaboration, the Nordics aim to create a medical system where every treatment is both effective and necessary.
Patient Safety Comes First
While budgetary concerns play a role in these initiatives, the primary focus remains patient safety and clinical integrity. Medical professionals stress that eliminating ineffective treatments is not just about saving money but ensuring that every patient receives care that is proven to help.
Through systematic testing and strict scientific review, healthcare providers hope to eliminate outdated or harmful practices. The goal is a future where all care provided in intensive care units, and across the healthcare system, is supported by reliable, evidence-based science.
